Forest Laboratories Inc (FRX.N)
41.71USD
4:00pm EDT
$-0.01 (-0.02%)
$41.72
$41.69
$41.95
$41.55
317,657
425,960
$43.85
$31.28
FRX.N
About
Overall
| Beta: | 0.76 |
| Market Cap (Mil.): | $11,125.47 |
| Shares Outstanding (Mil.): | 266.67 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| FRX.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 32.01 | 32.18 |
| EPS (TTM): | -0.12 | -- | -- |
| ROI: | -0.49 | 19.61 | 18.91 |
| ROE: | -0.56 | 20.45 | 19.87 |
Forest Labs says trial results positive for hypertension drug
June 27 - Forest Laboratories Inc said on Thursday that combining Bystolic, the brand name for nebivolol, and valsartan to treat hypertension in a clinical trial was more effective at lowering blood pressure than either nebivolol or valsartan alone at eight weeks.
Wall St. plunges, S&P posts biggest drop since Nov 2011
NEW YORK - Stocks fell more than 2 percent on Thursday, extending the previous day's sharp decline as investors fretted over the Federal Reserve's plan to begin reducing its stimulus later this year if the economy strengthens. | Video
US STOCKS-Wall Street drops in wake of Fed stimulus wind-down plan
NEW YORK, June 20 - The Federal Reserve's plans to begin winding down its massive monetary stimulus later this year hurt shares on Wall Street for a second day Thursday, putting the S&P on track for its worst two-day run in seven months.
US STOCKS-Wall Street falls after Fed's stimulus wind-down outline
NEW YORK, June 20 - U.S. stocks fell 1 percent for a second day on Thursday after Federal Reserve Chairman Ben Bernanke outlined the start of a wind-down of stimuli that has been instrumental to the market's rally.
US STOCKS-Wall St to slide after Fed's stimulus wind-down outline
NEW YORK, June 20 - U.S. stocks were set to slide at the open on Thursday, adding to a more than 1 percent drop a day earlier, after Federal Reserve Chairman Ben Bernanke outlined the start of a wind-down of stimuli that has been instrumental to the market's rally.
US STOCKS-Futures fall in wake of Fed's stimulus wind-down outline
NEW YORK, June 20 - U.S. stock index futures fell on Thursday, adding to a more than 1 percent drop in U.S. equities a day earlier, after Federal Reserve Chairman Ben Bernanke outlined the start of a wind-down of stimuli that has been instrumental to the market's rally.
US STOCKS-Futures drop in wake of Fed's stimulus-tapering outline
NEW YORK, June 20 - U.S. stock index futures fell on Thursday, adding to a more than 1 percent drop in U.S. equities a day earlier, after Federal Reserve Chairman Ben Bernanke outlined the start of a wind-down of stimuli that has been instrumental to the market's rally.
Exclusive: Forest mulls bid for Irish drugmaker Elan - sources
NEW YORK - Forest Laboratories Inc, the specialty drugmaker that counts investor Carl Icahn as a major shareholder, is among a handful of companies interested in bidding for Irish drugmaker Elan Corp Plc, two people familiar with the situation said.
Forest Labs to add Icahn rep to board, avert proxy fight
- Forest Laboratories Inc said on Tuesday it will add a representative of Carl Icahn as an independent member to its board, averting a new proxy battle with the billionaire investor.
UPDATE 2-Forest Labs to add Icahn rep to board, avert proxy fight
June 11 - Forest Laboratories Inc said on Tuesday it will add a representative of Carl Icahn as an independent member to its board, averting a new proxy battle with the billionaire investor.
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $27.70 | -0.08 |
| Johnson & Johnson (JNJ.N) | $86.57 | -0.06 |
| Novartis AG (NOVN.VX) | CHF67.45 | +0.15 |
| Roche Holding Ltd. (ROG.VX) | CHF235.70 | +1.10 |
| Abbott Laboratories (ABT.N) | $34.86 | -0.17 |
| AstraZeneca plc (AZN.L) | 3,173.00p | +22.00 |
| GlaxoSmithKline plc (GSK.L) | 1,670.00p | +11.50 |
| Eli Lilly & Co. (LLY.N) | $50.50 | +0.34 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 14,240.00₪ | +110.00 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (FRX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
